Anti-rejection Drug May Increase Risk Of Diabetes After Kidney Transplant
Sunday, May 25, 2008 - 23:28
in Health & Medicine
For patients undergoing kidney transplantation, treatment with the anti-rejection drug sirolimus may lead to an increased risk of diabetes, reports a new study. The results suggested a higher rate of post-transplant diabetes among patients treated with sirolimus, compared to other anti-rejection drugs. Depending on which additional drugs they received, diabetes risk was 36 to 66 percent higher for patients receiving sirolimus.